Publications by authors named "Richard Begent"

Claim this Profile
I
IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.
John Marquardt, Richard H J Begent, Kerry Chester, James S Huston, Andrew Bradbury

MAbs· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA.
Peter-Christian Klöhn, Ulrich Wuellner, Nora Zizlsperger, Yu Zhou, Daniel Tavares, Richard H J Begent

MAbs· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapy.
Alejandra N González-Beltrán, May Y Yong, Gairin Dancey, Richard Begent

BMC Res Notes· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing a knowledge trail from molecular experiments to clinical trials.
May Yee Yong, Alejandra González-Beltrán, Richard Begent

N Biotechnol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcoidosis and testicular cancer: A case series and literature review.
Jonathan Dick, Richard H Begent, Tim Meyer

Urol Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observations and hypothesis on an individual patient topically treated for capecitabine-induced Palmar-Plantar syndrome.
Arie R Gafson, Olivia Goodkin, Richard Begent

BMJ Case Rep· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best use of experimental data in cancer informatics.
May Yong, Richard Begent

Future Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells.
Kim L Vigor, Panagiotis G Kyrtatos, Shane Minogue, Khuloud T Al-Jamal, Heide Kogelberg, Richard H Begent

Biomaterials· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma.
Gairin Dancey, John Violet, Alessandra Malaroda, Alan J Green, Surinder K Sharma, Richard Begent

Clin Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake.
Jason L J Dearling, Aiden A Flynn, Uzma Qureshi, Stephen Whiting, Geoffrey M Boxer, Richard H J Begent

Nucl Med Biol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From practice guidelines to clinical decision support: closing the loop.
John Fox, Vivek Patkar, Ioannis Chronakis, Richard Begent

J R Soc Med· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging in targeted delivery of therapy to cancer.
Gairin Dancey, Richard H Begent, Tim Meyer

Target Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncology Information Exchange opens up databases.
Richard Begent

Lancet Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomas.
Tim Meyer, Andrew M Gaya, Gairin Dancey, Michael R L Stratford, Shokri Othman, Richard H Begent

Clin Cancer Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors.
Daniel Hochhauser, Timothy Meyer, Victoria J Spanswick, Jenny Wu, Peter H Clingen, Richard H Begent

Clin Cancer Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus.
Heide Kogelberg, Berend Tolner, Gareth J Thomas, Danielle Di Cara, Shane Minogue, Richard H J Begent

J Mol Biol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy.
Elena F Fidarova, Ethaar El-Emir, Geoffrey M Boxer, Uzma Qureshi, Jason L J Dearling, Richard H J Begent

Clin Cancer Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of recombinant protein in Pichia pastoris by fermentation.
Berend Tolner, Lisa Smith, Richard H J Begent, Kerry A Chester

Nat Protoc· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpretation of treatment results with biological agents: is there a need for a new methodology?
Richard H Begent

J BUON· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded-bed adsorption immobilized-metal affinity chromatography.
Berend Tolner, Lisa Smith, Richard H J Begent, Kerry A Chester

Nat Protoc· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incentivizing standards development and adoption.
Fiona Reddington, J Max Wilkinson, Robin Clark, Richard H Begent

Nat Biotechnol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy.
Jason L J Dearling, Uzma Qureshi, Richard H J Begent, R Barbara Pedley

Clin Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer informatics in the U.K.: the NCRI informatics initiative.
Fiona Reddington, J Max Wilkinson, Robin Clark, Helen Parkinson, Peter Kerr, Richard Begent

Cancer Inform· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy.
Heide Kogelberg, Berend Tolner, Surinder K Sharma, Mark W Lowdell, Uzma Qureshi, Richard H J Begent

Glycobiology· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug.
Astrid Mayer, Roslyn J Francis, Surinder K Sharma, Berend Tolner, Caroline J Springer, Richard H J Begent

Clin Cancer Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis